PuriCore PLC

Realm Therapeutics PLC , which last November launched a strategic review, said it plans to sell assets for up to $10m to Urgo US Inc , delist from London's AIM market, while continuing to hold discus

The writing is on the wall for Realm Therapeutics which has decided to discontinue all of its drug development programs and put up the 'for sale' sign following the high-profile failure this summer of

Top-line results from a Phase II study of Realm Therapeutics ' hypochlorous acid-containing lead product, PR022, in atopic dermatitis, are expected in the third quarter of 2018, and if positive shoul

IN VITRO DIAGNOSTICS Mergers & Acquisitions Immucor Inc. Organ-I Inc. Immucor Inc. acquired fellow privately held transplant diagnostics company Organ-I Inc. (Jun.) Organ-I spun out of Stanf